ES2070868T3 - Proteasa polifuncional. - Google Patents
Proteasa polifuncional.Info
- Publication number
- ES2070868T3 ES2070868T3 ES89110277T ES89110277T ES2070868T3 ES 2070868 T3 ES2070868 T3 ES 2070868T3 ES 89110277 T ES89110277 T ES 89110277T ES 89110277 T ES89110277 T ES 89110277T ES 2070868 T3 ES2070868 T3 ES 2070868T3
- Authority
- ES
- Spain
- Prior art keywords
- optimal
- protease
- mna
- suc
- mca
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/16—Organic compounds
- C11D3/38—Products with no well-defined composition, e.g. natural products
- C11D3/386—Preparations containing enzymes, e.g. protease or amylase
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/40—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/58—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from fungi
- C12N9/60—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from fungi from yeast
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6402—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from non-mammals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/911—Microorganisms using fungi
- Y10S435/94—Saccharomyces
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/911—Microorganisms using fungi
- Y10S435/94—Saccharomyces
- Y10S435/942—Saccharomyces cerevisiae
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Mycology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cell Biology (AREA)
- Enzymes And Modification Thereof (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
LA INVENCION SE REFIERE A UNA PROTEASA POLIFUNCIONAL HUMANA CARACTERIZADA PORQUE LA PROTEASA TIENE LAS SIGUIENTES PROPIEDADES: A) ACTIVIDAD ENZIMATICA CAPAZ DE ROMPER EL SUSTRATO SINTETICO DE CBZ - LEN - LEN - GLU - NA (DONDE CBZ ES N BENCILOXICARBONILO Y NA ES 2 - NAFTILAMIDO), Y UN PH OPTIMO DE 8.4 A 8.6; B) ACTIVIDAD ENZIMATICA CAPAZ DE ROMPER EL SUSTRATO DE CBZ - ABA - ARG - ARG - MNA (DONDE MNA ES 4 - METOXI - 2 NAFTILAMIDO) Y UN PH OPTIMO DE 9.8 A 10.1; C) ACTIVIDAD ENZIMATICA CAPAZ DE ROMPER EL SUSTRATO SINTETICO DE SUC - LEN LEN - VAL - TYR - MCA (DONDE SUC ES SUCCINILO, Y MCA ES 4 - METIL - 7 - CUMARILAMIDO) Y UN PH OPTIMO DE 8.4 A 8.6; D) UN ESPECTRO DE ABSORCION UV CON UNA ABSORCION MAXIMA (LAMBDA MAX) A 278 NM Y UNA ABSORCION DE E1CM1% = 11.2A 280 NM; E) UNA CONSTANTE DE SEDIMENTACION DE 21.8 S DETERMINADA POR EL METODO DE VELOCIDAD DE SEDIMENTACION; F) UN PESO MOLECULAR DE 870000+-50000.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP63142526A JPH01309686A (ja) | 1988-06-08 | 1988-06-08 | 多機能プロテアーゼ |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2070868T3 true ES2070868T3 (es) | 1995-06-16 |
Family
ID=15317407
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES89110277T Expired - Lifetime ES2070868T3 (es) | 1988-06-08 | 1989-06-07 | Proteasa polifuncional. |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US5425942A (es) |
| EP (1) | EP0345750B1 (es) |
| JP (1) | JPH01309686A (es) |
| KR (1) | KR910001039A (es) |
| DE (1) | DE68922340T2 (es) |
| DK (1) | DK277689A (es) |
| ES (1) | ES2070868T3 (es) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5459035A (en) * | 1988-12-15 | 1995-10-17 | Amdl, Inc. | Method of detecting the tumors using ring shaped particles as a tumor marker |
| WO1992007269A1 (en) * | 1990-10-11 | 1992-04-30 | Pro-Soma S.A.R.L. | Diagnostic method |
| FI922667A0 (fi) * | 1990-10-12 | 1992-06-09 | Pro Soma Sarl | Diagnostiskt foerfarande. |
| ZA923679B (en) * | 1991-06-21 | 1993-01-27 | Pro Soma Sarl | Diagnostic method |
| US5872206A (en) * | 1994-10-06 | 1999-02-16 | The General Hospital Corporation | Compositions and methods for interfering wtih hepatitis B virus infection |
| WO1998007819A1 (en) * | 1996-08-16 | 1998-02-26 | The Procter & Gamble Company | Detergent compositions comprising antibody controlled proteolytic activity |
| WO1998007820A1 (en) * | 1996-08-16 | 1998-02-26 | The Procter & Gamble Company | Detergent compositions comprising antibody controlled enzymatic activity |
| EP0968279A1 (de) * | 1997-03-21 | 2000-01-05 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Verfahren zur reinigung und kristallisierung von proteasom |
| DE10232902A1 (de) * | 2002-07-19 | 2004-01-29 | Bayer Cropscience Ag | Verfahren zum Identifizieren von Inhibitoren des 20S und 26S Proteasoms |
| AU2003268355A1 (en) * | 2002-09-03 | 2004-03-29 | The Uab Research Foundation | Localization of human cytomegalovirus nucleic acids and proteins in human cancer cells |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RO57973A (es) * | 1969-06-13 | 1975-03-15 | ||
| FR2233038A1 (en) * | 1973-05-30 | 1975-01-10 | Innerfield Irving | Thrombosis treatment - by oral administration of a protease |
-
1988
- 1988-06-08 JP JP63142526A patent/JPH01309686A/ja active Pending
-
1989
- 1989-06-07 ES ES89110277T patent/ES2070868T3/es not_active Expired - Lifetime
- 1989-06-07 DE DE68922340T patent/DE68922340T2/de not_active Expired - Fee Related
- 1989-06-07 DK DK277689A patent/DK277689A/da not_active Application Discontinuation
- 1989-06-07 EP EP89110277A patent/EP0345750B1/en not_active Expired - Lifetime
- 1989-06-08 KR KR1019890007967A patent/KR910001039A/ko not_active Ceased
-
1993
- 1993-03-05 US US08/027,595 patent/US5425942A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP0345750A3 (en) | 1992-06-03 |
| JPH01309686A (ja) | 1989-12-14 |
| DE68922340T2 (de) | 1995-10-26 |
| DK277689A (da) | 1989-12-09 |
| DK277689D0 (da) | 1989-06-07 |
| EP0345750A2 (en) | 1989-12-13 |
| EP0345750B1 (en) | 1995-04-26 |
| KR910001039A (ko) | 1991-01-30 |
| DE68922340D1 (de) | 1995-06-01 |
| US5425942A (en) | 1995-06-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2070868T3 (es) | Proteasa polifuncional. | |
| CY1105836T1 (el) | 12, 13-τροποποιημενα παραγωγα εποθιλονης | |
| ATE461271T1 (de) | Verfahren zur herstellung von l-aminosäure | |
| FI933566A0 (fi) | Nytt foerfarande foer framstaellning av 7-(substituerade)-9-((substituerad glycyl)amido)-6-demetyl-6-deoxitetracykliner | |
| ES2139183T3 (es) | Inhibidores de las metaloproteinasas. | |
| NO903286L (no) | Antibakterielle midler. | |
| EA200300135A1 (ru) | Замещенные соединения матациклина (варианты), фармацевтическая композиция (варианты) и способ лечения чувствительного к тетрациклину состояния млекопитающего (варианты) | |
| DE69306298D1 (de) | Anticonvulsive Fructopyranose zyklische Sulfate und Sulfite | |
| TR199701490A2 (xx) | 3-Hidroksipiridin-2-karbonasitamidester ve bunlar�n imalat�. | |
| ES2191208T3 (es) | Oxiimino-pregnano-carbolactonas. | |
| ES2042868T3 (es) | Un metodo de producir galidermina. | |
| DE3676922D1 (de) | Neue polyoxygenierte labdan-derivate, verfahren zu ihrer herstellung und ihre anwendung als medikamente. | |
| ATE126532T1 (de) | Modifizierte protease, verfahren zu deren herstellung und diese enthaltende kosmetische zusammensetzungen. | |
| BR9506866A (pt) | Composiçao biologicamente purificada composiçao para utilizaçao como um agente anti-inflamatório processo para o tratamento de mamíferos tendo tecido inflamado e processo para á produçao de ciclomarin-a | |
| ES2142490T3 (es) | Ciclopeptolidos. | |
| ES2131297T3 (es) | Nuevos derivados de bencenosulfonilamina como inhibidores de la accion il-1. | |
| ATE83480T1 (de) | Cyclisches peptid, seine herstellung und seine verwendung zur behandlung von cardiovasculaeren stoerungen. | |
| FI971276A0 (fi) | Lerk-6:ksi nimetty sytokiini | |
| ATE51229T1 (de) | Oxa- und thiadiazolylderivate und ihre verwendung. | |
| ES2026485T3 (es) | Esteres de salsalato con guayacol para tratar bronconeumopatias flogisticas. | |
| BR9807144A (pt) | Microorganismos com produção acrescida de ácido clavulânico | |
| EP0259751A3 (de) | Annomycin, ein Antibiotikum; mikrobiologisches Verfahren zu dessen Herstellung und seine Verwendung | |
| ES2139341T3 (es) | Isocomarinas antitumorales. | |
| DE60314769D1 (de) | Reinigungsverfahren von 1,4-butanediol mononitrat | |
| ES2109962T3 (es) | Derivados de la naftiridina condensados. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG2A | Definitive protection |
Ref document number: 345750 Country of ref document: ES |